Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-031329
Filing Date
2023-09-05
Accepted
2023-09-05 10:09:19
Documents
14
Period of Report
2023-09-05

Document Format Files

Seq Description Document Type Size
1 6-K a230905_6kxmorxvotingright.htm 6-K 12215
2 EX-99.1 exhibit_991.htm EX-99.1 6615
3 EX-99.2 exhibit_992.htm EX-99.2 6269
4 GRAPHIC exhibit_991001.jpg GRAPHIC 120335
5 GRAPHIC exhibit_991002.jpg GRAPHIC 127102
6 GRAPHIC exhibit_991003.jpg GRAPHIC 122453
7 GRAPHIC exhibit_991004.jpg GRAPHIC 95065
8 GRAPHIC exhibit_991005.jpg GRAPHIC 96462
9 GRAPHIC exhibit_991006.jpg GRAPHIC 25058
10 GRAPHIC exhibit_992001.jpg GRAPHIC 119985
11 GRAPHIC exhibit_992002.jpg GRAPHIC 128927
12 GRAPHIC exhibit_992003.jpg GRAPHIC 131159
13 GRAPHIC exhibit_992004.jpg GRAPHIC 89997
14 GRAPHIC exhibit_992005.jpg GRAPHIC 88750
  Complete submission text file 0001628280-23-031329.txt   1604279
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 231234416
SIC: 2834 Pharmaceutical Preparations